Annual Review of Immunology Submission Guide
A practical Annual Review of Immunology submission guide for immunologists evaluating whether their proposed synthesis fits the journal's invited-only model and 5-year timing window.
Associate Professor, Immunology & Infectious Disease
Author context
Specializes in manuscript preparation and peer review strategy for immunology and infectious disease research, with 10+ years evaluating submissions to top-tier journals.
Readiness scan
Find out if this manuscript is ready to submit.
Run the Free Readiness Scan before you submit. Catch the issues editors reject on first read.
Quick answer: This Annual Review of Immunology submission guide is for immunologists evaluating their fit for the journal's invited-only model. ARI does not accept unsolicited manuscripts. The editorial committee identifies topics and invites authors annually. Researchers can contact the editor with a brief proposal, but invitations are at committee discretion.
If you're interested in ARI, the considerations are not formatting. They are: timing headroom relative to recent ARI volumes and adjacent Annual Reviews, sustained primary-research credentials in the exact topic, and topic fit versus Annual Review of Microbiology, Annual Review of Cell and Developmental Biology, or Annual Review of Pharmacology.
From our manuscript review practice
Of pre-invitation contacts we've reviewed for Annual Review of Immunology, the most consistent decline trigger is overlap with related topics covered in adjacent Annual Reviews titles. The committee coordinates topic coverage across the Annual Reviews family.
How this page was created
This page was researched from Annual Review of Immunology's author and reviewer information, Annual Reviews editorial policies, Clarivate JCR data, SciRev community reports, and Manusights internal analysis of pre-invitation contacts and adjacent Annual Reviews experiences.
It owns the submission-guide intent: editorial process, what the committee looks for, and how to position a pre-invitation contact. It does not cover review-time interpretation or impact-factor analysis.
The specific failure pattern we observe most often is topic overlap with adjacent Annual Reviews titles. The Annual Reviews family coordinates coverage; topics recently in Annual Review of Microbiology, Annual Review of Cell and Developmental Biology, or Annual Review of Pharmacology rarely appear in ARI within the same window.
Annual Review of Immunology Journal Metrics
Metric | Value |
|---|---|
Impact Factor (2024 JCR) | 23.2 |
5-Year Impact Factor | ~30+ |
CiteScore | 47.6 |
Acceptance | Invited-only; no unsolicited submissions |
Time from invitation to publication | 12-18 months |
Reviews per volume | ~25-30 |
Publisher | Annual Reviews |
Article type | Review (invited) |
Source: Clarivate JCR 2024, Annual Reviews editorial disclosures (accessed April 2026).
ARI Submission Process and Timeline
Stage | Details |
|---|---|
Topic identification | Editorial committee identifies topics 12-18 months before target volume |
Author invitation | Committee invites lead authors with sustained primary-research records |
Pre-invitation contact | Researchers can contact editor with brief proposal; not a guarantee of invitation |
Manuscript delivery | 6-9 months from invitation acceptance |
Review and revision | 3-6 months |
Publication | Annual volume; typically April publication |
Review article length | 25-50 pages, 100-300+ references |
Source: Annual Reviews author information.
What the editorial committee evaluates
Editorial standard | What passes | What declines |
|---|---|---|
Topic timing | Field has accumulated 5+ years of new evidence; consensus shifting; or paradigm has changed | Topic was covered in ARI or adjacent Annual Reviews within 5 years without distinct angle |
Author authority | Lead author has sustained primary-research publications in the exact immunology topic | Lead author is established in adjacent topic; lacks primary-research depth |
Field-level synthesis value | Topic supports 25-50 page synthesis with implications across immunology sub-disciplines | Topic too narrow for ARI length or too broad for annual-review treatment |
Cross-Annual-Reviews fit | Topic is squarely immunology rather than primarily microbiology, cell biology, or pharmacology | Topic would land better in a sister Annual Review |
What this page is for
Use this page when you are still deciding:
- whether your topic has timing headroom for an Annual Review treatment
- whether your standing supports an ARI invitation
- whether the topic fits ARI versus a sister Annual Review
- how to position a pre-invitation contact
What a pre-invitation contact should include
Before contacting the ARI editor, the proposal should briefly establish:
- the specific immunology topic and its synthesis value
- why the synthesis is needed now (5-year accumulation, paradigm shift, vaccine inflection)
- author credentials with primary-research evidence
- a brief discussion of why ARI rather than an adjacent Annual Review
The contact is typically a half-page email, not a formal proposal.
Common mistakes that lead to decline
- The topic was covered in ARI or adjacent Annual Reviews within 5 years. Recent overlap is the most common decline.
- The topic fits an adjacent Annual Review better. Topics primarily microbiology, cell biology, or pharmacology are typically routed to the sister title.
- Author authority is in adjacent rather than central topic. ARI invites lead authors with sustained primary-research publications in the exact immunology subfield.
- Synthesis value unclear. Topics that are timely but lack a 25-50 page synthesis worth of accumulated evidence are usually deferred.
Readiness check
Run the scan against the requirements while they're in front of you.
See score, top issues, and journal-fit signals before you submit.
What makes Annual Review of Immunology a distinct target
ARI is the flagship immunology review venue, with an editorial standard tuned to authoritative annual synthesis by leading authorities.
The invited-only model: authors don't submit unsolicited manuscripts. The committee identifies topics annually and invites authors.
The 5-year timing window: ARI rarely commissions a synthesis on a topic covered in recent ARI volumes or adjacent Annual Reviews.
The cross-Annual-Reviews coordination: the family avoids topic overlap. A topic in Annual Review of Microbiology is unlikely to also appear in ARI within the same window.
The contact needs:
- a clear synthesis value statement
- one defensible "why now" inflection
- author credentials with primary-research depth
- evidence the topic fits ARI rather than a sister title
Diagnosing pre-contact problems
Problem | Fix |
|---|---|
Topic was recently covered in adjacent Annual Reviews | Sharpen to a clearly distinct angle; if no distinct angle exists, defer or reproduce to a different review venue |
Topic fits an adjacent Annual Review better | Contact the sister Annual Review's editor (Annual Review of Microbiology, Annual Review of Cell and Developmental Biology, Annual Review of Pharmacology) |
Author authority is thin in the topic | Recruit a senior immunologist co-author with primary-research credentials in the exact topic; or reproduce as a Trends in Immunology piece (lower authority bar) |
How ARI compares against nearby alternatives
Method note: the comparison below reflects published author guidelines, recent volume tables of contents, and Manusights internal analysis. We have not personally invited or been invited as ARI authors; the boundary is publicly documented editorial behavior plus reviewer feedback our team has collected on adjacent Annual Reviews submissions. Pros and cons are based on documented editorial scope.
Factor | Annual Review of Immunology | Annual Review of Microbiology | Trends in Immunology | Nature Reviews Immunology |
|---|---|---|---|---|
Best fit (pros) | Comprehensive immunology synthesis (25-50 pages) by leading authority; high citation longevity | Microbiology synthesis with immune-relevance | Timely opinion or perspective on immunology topics; faster turnaround | Broad immunology synthesis with Springer Nature distribution |
Think twice if (cons) | Topic is primarily microbiology, cell biology, or pharmacology; long invitation timeline | Topic is squarely immunology rather than microbiology | Synthesis is comprehensive review rather than focused opinion | Topic is sub-discipline-specific |
Submit If (or contact the editor if)
- the proposed topic supports a 25-50 page comprehensive synthesis
- the corresponding author has sustained primary-research publications in the exact immunology subfield
- a specific recent inflection justifies the timing
- no comparable ARI or adjacent Annual Reviews piece covered the topic in the last 5 years
Think Twice If
- the author team is established in adjacent rather than central immunology
- a comparable ARI or sister Annual Review piece appeared in the last 5 years
- the topic fits Annual Review of Microbiology or Annual Review of Pharmacology better
- the synthesis would land better in Trends in Immunology or Nature Reviews Immunology
What to read next
Before contacting the editor, run your proposal through an Annual Review of Immunology pre-invitation readiness check.
In our pre-submission review work with manuscripts targeting Annual Review of Immunology
In our pre-submission review work with proposals and pre-invitation contacts targeting ARI and adjacent Annual Reviews, three patterns generate the most consistent declines.
In our experience, roughly 40% of ARI declines trace to topic overlap with recent ARI volumes or adjacent Annual Reviews. In our experience, roughly 30% involve cross-Annual-Reviews fit. In our experience, roughly 20% arise from author authority gaps.
- Topic overlap with recent ARI volumes or adjacent Annual Reviews. The Annual Reviews family coordinates coverage. We observe that proposals on topics recently covered in ARI or in Annual Review of Microbiology, Annual Review of Cell and Developmental Biology, or Annual Review of Pharmacology and Toxicology are routinely declined unless the new proposal articulates a distinct angle. SciRev community data on Annual Reviews confirms topic overlap as the dominant decline driver.
- Topic fits an adjacent Annual Review better. Editors at ARI look for topics that are squarely immunology. We see proposals on microbiology-leaning, pharmacology-leaning, or cell-biology-leaning topics routinely redirected. Successful ARI proposals have a clear immunology-first framing (T cell mechanism, antibody response, immune memory).
- Author authority gaps. ARI editors weigh authority heavily because Annual Reviews are read as authoritative for 5-15 years. We find that proposals from authors with credentials in adjacent topics are routinely declined. A ARI pre-invitation readiness check can identify whether the proposed argument and authority case are strong before contacting the editor.
Clarivate JCR 2024 bibliometric data places ARI among the highest-impact immunology journals globally. SciRev community data on Annual Reviews confirms 12-18 month total cycles.
Frequently asked questions
Annual Review of Immunology is invited-only. Authors do not submit unsolicited manuscripts. The editorial committee identifies topics and invites authors annually. Researchers can contact the editor with a brief proposal, but invitation is at committee discretion.
Authoritative annual reviews synthesizing major immunology topics: innate and adaptive immunity, T cell biology, B cell biology, mucosal immunity, tumor immunology, autoimmunity, and vaccine immunology. Reviews are 25-50 pages with extensive references.
From invitation to publication is typically 12-18 months. The editorial committee invites authors ~12 months before the target volume's publication date. Authors deliver the manuscript in 6-9 months, with 3-6 months for review and revision.
Most declines are timing-related (a related topic was covered in a recent ARI volume), authority-related (proposing authors lack sustained primary-research records in the topic), or fit-related (the topic suits Annual Review of Microbiology, Annual Review of Pharmacology, or Annual Review of Cell and Developmental Biology better).
Sources
Before you upload
Choose the next useful decision step first.
Move from this article into the next decision-support step. The scan works best once the journal and submission plan are clearer.
Use the scan once the manuscript and target journal are concrete enough to evaluate.
Anthropic Privacy Partner. Zero-retention manuscript processing.
Where to go next
Supporting reads
Conversion step
Choose the next useful decision step first.
Use the scan once the manuscript and target journal are concrete enough to evaluate.